A Case Series of a Hybrid Approach to Aortic Arch Disease
DOI:
https://doi.org/10.1532/HSF98.20131022Abstract
Objective: Debranching of the aortic arch and endovascular stent placement as a combination therapy for complex aortic arch pathology has emerged over the past few years as an alternative to traditional repair. This hybrid approach is a viable option for patients who would not tolerate conventional arch replacement, as well as for patients with a failed stent graft of the descending aorta and a subsequent type I endoleak.
Methods: We retrospectively reviewed the preoperative characteristics and postoperative outcomes of 5 patients who underwent debranching of the aortic arch and implantation of an endovascular stent across the aortic arch between 2008 and 2011. Data were analyzed with the Student t test and the Kaplan-Meyer method.
Results: The mean age was 70.6 ± 18 years; 4 men and 1 woman were evaluated. One patient had previous aortic surgery for dissection. The preoperative morbidities included arrhythmia (1 patient), chronic obstructive pulmonary disease (2 patients), cerebrovascular accident (1 patient), diabetes mellitus (2 patients), coronary artery disease (2 patients), and active angina (1 patient). One patient had a myocardial infarction 3 weeks before surgery. The primary technical-success rate was 100%, and none of the patients died in the perioperative phase. The mean follow-up time was 22 ± 18.4 months, and the median follow-up time was 13.8 months (range, 7.13-50.7 months). Two patients died during follow-up. The pathology of the aorta in the patients who died was arch aneurysm; the 3 remaining patients are alive and regularly followed at our institution.
Conclusion: The combination of surgery and simultaneous endovascular stenting in the operating room is an alternative approach for patients who are poor candidates for traditional arch repair under circulatory arrest.
References
Bavaria J, Milewski RK, Baker J, Moeller P, Szeto W, Pochettino A. 2010. Classic hybrid evolving approach to distal arch aneurysms: toward the zone zero solution. J Thorac Cardiovasc Surg 140(suppl):S77-80; discussion S86-91.nBavaria J, Vallabhajosyula P, Moeller P, Szeto W, Desai N, Pochettino A. 2013. Hybrid approaches in the treatment of aortic arch aneurysms: postoperative and midterm outcomes. J Thorac Cardiovasc Surg 145(suppl):S85-90.nBrueck M, Heidt MC, Szente-Varga M, Bandorski D, Kramer W, Vogt PR. 2006. Hybrid treatment for complex aortic problems combining surgery and stenting in the integrated operating theater. J Interv Cardiol 19:539-43.nCires G, Noll RE Jr, Albuquerque FC Jr, Tonnessen BH, Sternbergh WC 3rd. 2011. Endovascular debranching of the aortic arch during thoracic endograft repair. J Vasc Surg 53:1485-91.nCzerny M, Zimpfer D, Fleck T, et al. 2004. Initial results after combined repair of aortic arch aneurysms by sequential transposition of the supra-aortic branches and consecutive endovascular stent-graft placement. Ann Thorac Surg 78:1256-60.nFerrero E, Ferri M, Viazzo A, et al. 2012. Is total debranching a safe procedure for extensive aortic-arch disease? A single experience of 27 cases. Eur J Cardiothorac Surg 41:177-82.nGottardi R, Funovics M, Eggers N, et al. 2008. Supra-aortic transposition for combined vascular and endovascular repair of aortic arch pathology. Ann Thorac Surg 86:1524-9.nKoullias GJ, Wheatley GH 3rd. 2010. State-of-the-art of hybrid procedures for the aortic arch: a meta-analysis. Ann Thorac Surg 90:689-97.nNeragi-Miandoab S, Tuchak J, Bakhos M, Schwartz JP. 2006. Open repair of a new aneurysm of the thoracoabdominal aorta after endovascular stent placement. J Thorac Cardiovasc Surg 132:157-8.nRiambau V, Zipfel B, Coppi G, et al. 2011. Final operative and midterm results of the European experience in the RELAY Endovascular Registry for Thoracic Disease (RESTORE) study. J Vasc Surg 53:565-73.nSchwartz JP, Bakhos M, Patel A, Botkin S, Neragi-Miandoab S. 2008. Repair of aortic arch and the impact of cross-clamping time, New York Heart Association stage, circulatory arrest time, and age on operative outcome. Interact Cardiovasc Thorac Surg 7:425-9.nTiesenhausen K, Hausegger KA, Oberwalder P, et al. 2003. Left subclavian artery management in endovascular repair of thoracic aortic aneurysms and aortic dissections. J Card Surg 18:429-35.nTorsello GB, Torsello GF, Osada N, Teebken OE, Ratusinski CM, Nienaber CA. 2010. Midterm results from the TRAVIATA registry: Treatment of Thoracic Aortic Disease with the Valiant Stent Graft. J Endovasc Ther 17:137-50.nVallejo N, Rodriguez-Lopez JA, Heidari P, et al. 2012. Hybrid repair of thoracic aortic lesions for zone 0 and 1 in high-risk patients. J Vasc Surg 55:318-25.nYilik L, Gokalp O, Yurekli I, et al. 2012. Hybrid repair of aortic arch aneurysms in same session. Thorac Cardiovasc Surg 60:501-7.nYounes HK, Davies MG, Bismuth J, et al. 2010. Hybrid thoracic endovascular aortic repair: pushing the envelope. J Vasc Surgery 51:259-66.n
Published
How to Cite
Issue
Section
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).
